-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
Pulmonary tuberculosis treated with "onnetsu" far infrared rays: a case report
Aranda-Ventura Jose, Tatsumura-Hillyer Kazuko
Case Report: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
A review of rifapentine for treating active and latent tuberculosis
Michelle K Haas, Robert W Belknap
Review Article: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Personalized medicine in rheumatoid arthritis: rationale & clinical evidence
BC Visser, IH Brinkman, MAFJ van de Laar
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Emergence of Neisseria meningitidis W-135 in the context of other rare serogroups
Luiz Jacintho da Silva, Lisa DeTora, Claudius Malerczyk & Ziad A Memish
Therapeutic Perspective: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Phase III study shows promising results for personalized medicine in advanced melanoma
News and Views: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
Roflumilast for the treatment of respiratory disease: review of the Phase II and III trials
Sabina Antonela Antoniu
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation
-
New approaches to the design of sublingual immunotherapy clinical trials
Enrico Compalati, Anthi Rogkakou, Alberto Bordo, Giorgio Walter Canonica, Giovanni Passalacqua
Review Article: Clinical Investigation